Literature DB >> 3025013

Poliomyelitis immunity status at different intervals from vaccination.

E Bellelli, U Bracchi, M L Tanzi, G Benaglia, G Montanarini.   

Abstract

Research on neutralizing antibodies against the 3 serotypes of poliovirus was carried out on 441 blood specimens drawn from children and young people living in Parma, a town of about 200,000 inhabitants, where the vaccination services were well organized. From June 1983 to June 1984 blood samples were taken from different groups of subjects at different stages of vaccination (before vaccination, and after 1, 2, 3, and 4 doses of trivalent balanced OPV). In addition, groups of children and young people vaccinated from 2 to more than 14 years earlier were bled. Ten per cent of unvaccinated babies (aged 1-3 months) were lacking in neutralizing antibodies for types 1 and 3 and five per cent for type 2; among children aged 4-5 months vaccinated by one dose of OPV a residual 5% of subjects without antibodies for type 1 was also found. All subjects who received two, three, or four doses, had antibodies against all serotypes of poliovirus. As for the number of administered doses, significant differences among GMTs of antibodies were recorded only for type 1, when the group given 3 doses, was compared with the group which received two and one dose, respectively. At different intervals from completion of vaccination (2-14 years), all groups we examined still had antibodies against all three serotypes. For poliovirus type 1 antibody, GMTs were not significantly different in the examined groups. For types 2 and 3 significant decreases were observed in the groups vaccinated from 2 to 5 years. The high levels of immunity observed earlier in Parma were not found throughout the entire territory.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3025013     DOI: 10.1007/BF00211532

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN: 0393-2990            Impact factor:   8.082


  29 in total

1.  Seroimmunity to poliomyelitis in an American community.

Authors:  T R Oberhofer; G C Brown; A S Monto
Journal:  Am J Epidemiol       Date:  1975-04       Impact factor: 4.897

2.  Methods for preparing tissue culture in disposable microplates and their use in virology.

Authors:  E J Sullivan; M J Rosenbaum
Journal:  Am J Epidemiol       Date:  1967-05       Impact factor: 4.897

3.  [Status of immunity to poliomyelitis in various population groups. II].

Authors:  G Nardi; E Bellelli; M L Tanzi; U Bracchi; V Monaci; A Corsello
Journal:  Ann Sclavo       Date:  1971 Sep-Oct

4.  Viral and epidemiological links between poliomyelitis outbreaks in unprotected communities in Canada and the Netherlands.

Authors:  J Furesz; R E Armstrong; G Contreras
Journal:  Lancet       Date:  1978-12-09       Impact factor: 79.321

5.  Prevalence of poliovirus neutralizing antibodies in young adult women.

Authors:  T R Mayer; H H Balfour
Journal:  JAMA       Date:  1981-09-11       Impact factor: 56.272

6.  Poliomyelitis in the United States, 1969-1981.

Authors:  M Moore; P Katona; J E Kaplan; L B Schonberger; M H Hatch
Journal:  J Infect Dis       Date:  1982-10       Impact factor: 5.226

Review 7.  Control of poliomyelitis: a continuing paradox.

Authors:  D M Horstmann
Journal:  J Infect Dis       Date:  1982-10       Impact factor: 5.226

8.  [Fecal excretion of poliovirus in subjects subjected to antipoliomyelitis vaccination].

Authors:  M R Biffi; A Tagger; F Bruscolini; L Salvaggio; A Albano
Journal:  Nuovi Ann Ig Microbiol       Date:  1982 Mar-Jun

9.  Comparison of antibody responses and virus shedding following administration of trivalent oral poliomyelitis vaccines prepared either in monkey or human diploid cell substrates.

Authors:  D S Freestone; A Kelly; R Ferris; R L Simmons; C Bowker; E Letley; C Bye
Journal:  J Hyg (Lond)       Date:  1980-02

10.  High and prolonged incidence of poliovirus strains during 1979 in North Bohemia. Isolations from unusual materials.

Authors:  V Kasová; J Koza; I Matyásová
Journal:  Zentralbl Bakteriol Mikrobiol Hyg A       Date:  1981-12
View more
  3 in total

1.  Antipoliomyelitis neutralizing antibodies in maternal and neonatal serum.

Authors:  M L Tanzi; P Colotto; M Vignali; P Affanni; U Bracchi; E Bellelli
Journal:  Eur J Epidemiol       Date:  1997-07       Impact factor: 8.082

2.  Antipoliomyelitis immunity status among a population that was regularly vaccinated 11-12 years before.

Authors:  E Bellelli; M L Tanzi; V Bocelli; U Bracchi; P Affanni
Journal:  Eur J Epidemiol       Date:  1991-11       Impact factor: 8.082

3.  Energy Metabolism-Related Gene Prognostic Index Predicts Biochemical Recurrence for Patients With Prostate Cancer Undergoing Radical Prostatectomy.

Authors:  Dechao Feng; Xu Shi; Facai Zhang; Qiao Xiong; Qiang Wei; Lu Yang
Journal:  Front Immunol       Date:  2022-02-24       Impact factor: 7.561

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.